NasdaqGS - Nasdaq Real Time Price USD

Zymeworks Inc. (ZYME)

8.26 +0.15 (+1.85%)
At close: April 26 at 4:00 PM EDT
7.66 -0.60 (-7.26%)
After hours: April 26 at 6:35 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
76,012.00
76,012.00
412,482.00
26,680.00
38,951.00
Operating Expense
214,019.00
214,019.00
281,996.00
242,352.00
226,403.00
Operating Income
-138,007.00
-138,007.00
130,486.00
-215,672.00
-187,452.00
Net Non Operating Interest Income Expense
19,705.00
19,705.00
3,596.00
1,965.00
5,697.00
Other Income Expense
-894.00
-894.00
1,110.00
1,309.00
1,648.00
Pretax Income
-119,242.00
-119,242.00
135,234.00
-212,359.00
-180,123.00
Tax Provision
-568.00
-568.00
10,893.00
-516.00
429.00
Net Income Common Stockholders
-118,674.00
-118,674.00
124,341.00
-211,843.00
-180,552.00
Average Dilution Earnings
--
--
-231.00
-28,534.00
--
Diluted NI Available to Com Stockholders
-118,674.00
-118,674.00
124,110.00
-240,377.00
-180,552.00
Basic EPS
-1.72
-1.72
1.91
-4.11
-3.58
Diluted EPS
-1.72
-1.72
1.90
-4.61
-3.58
Basic Average Shares
68,863.01
68,863.01
65,194.78
51,553.87
50,382.50
Diluted Average Shares
68,863.01
68,863.01
65,249.18
52,131.60
50,382.50
Total Operating Income as Reported
-138,053.00
-138,053.00
130,528.00
-215,633.00
-187,468.00
Total Expenses
214,019.00
214,019.00
281,996.00
242,352.00
226,403.00
Net Income from Continuing & Discontinued Operation
-118,674.00
-118,674.00
124,341.00
-211,843.00
-180,552.00
Normalized Income
-117,494.64
-117,494.64
123,281.79
-213,031.11
-181,780.59
Interest Income
19,705.00
19,705.00
3,596.00
1,965.00
5,697.00
Net Interest Income
19,705.00
19,705.00
3,596.00
1,965.00
5,697.00
EBIT
-138,007.00
-138,007.00
130,486.00
-215,672.00
-187,452.00
EBITDA
-120,702.00
-120,702.00
142,490.00
-206,089.00
-177,173.00
Reconciled Depreciation
17,305.00
17,305.00
12,004.00
9,583.00
10,279.00
Net Income from Continuing Operation Net Minority Interest
-118,674.00
-118,674.00
124,341.00
-211,843.00
-180,552.00
Total Unusual Items Excluding Goodwill
-1,185.00
-1,185.00
1,152.00
1,191.00
1,683.00
Total Unusual Items
-1,185.00
-1,185.00
1,152.00
1,191.00
1,683.00
Normalized EBITDA
-119,517.00
-119,517.00
141,338.00
-207,280.00
-178,856.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-5.64
-5.64
92.79
2.89
454.41
12/31/2020 - 4/28/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

STRO Sutro Biopharma, Inc.
3.4200
0.00%
 
BCAB BioAtla, Inc.
2.5400
+12.89%
 
ARCT Arcturus Therapeutics Holdings Inc.
26.55
+1.45%
 
VYGR Voyager Therapeutics, Inc.
7.62
+2.70%
 
BCYC Bicycle Therapeutics plc
22.73
+0.93%
 
BDTX Black Diamond Therapeutics, Inc.
5.89
+15.26%
 
CRGX CARGO Therapeutics, Inc.
18.68
+2.19%
 
QURE uniQure N.V.
4.5300
-0.22%
 
RCUS Arcus Biosciences, Inc.
15.55
+5.57%
 
MRSN Mersana Therapeutics, Inc.
2.9400
+3.16%